EUVIMEDObjevte EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease

Nishani Jayasooriya iD, Samantha Baillie iD, Jonathan Blackwell iD, Alex Bottle iD, Irene Petersen iD, Hanna Creese iD, Sonia Saxena iD, Richard C Pollok iD, POP-IBD study group

Alimentary Pharmacology & Therapeutics · 2023-03 · 57 (6) · 635-652

DOI: 10.1111/apt.17370 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2023-01-10. Written by Nishani Jayasooriya and 8 co-authors. Institution: Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK. Major MEDLINE topics: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Cited 155 times so far (Crossref); 148 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: School for Public Health Research.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

The impact of diagnostic delay on the clinical course of inflammatory bowel disease (IBD) remains uncertain.

Aim

To perform a systematic review of time to diagnosis and the impact of delayed diagnosis on clinical outcomes in Crohn's disease (CD) and ulcerative colitis (UC).

Methods

We searched EMBASE and Medline from inception to 30th November 2022 for studies reporting diagnostic interval, from symptom onset to IBD diagnosis. We calculated the median, interquartile range (IQR) and pooled weighted median, of median diagnostic intervals of eligible studies. We defined delayed diagnosis as individuals above the 75th centile of longest time to diagnosis in each study. Using random effects meta‐analysis, we pooled odds ratios (ORs) with 95% confidence intervals (CI) for studies reporting clinical outcomes, according to delayed diagnosis.

Results

One hundred and one studies representing 112,194 patients with IBD (CD = 59,359; UC = 52,835) met inclusion criteria. The median of median times to diagnosis was 8.0 (IQR: 5.0–15.2) and 3.7 months (IQR: 2.0–6.7) in CD and UC, respectively. In high‐income countries, this was 6.2 (IQR: 5.0–12.3) and 3.2 months (IQR: 2.2–5.3), compared with 11.7 (IQR: 8.3–18.0) and 7.8 months (IQR: 5.2–21.8) in low‐middle‐income, countries, for CD and UC respectively. The pooled weighted median was 7.0 (95% CI: 3.0–26.4) and 4.6 (95% CI: 1.0–96.0) months, for CD and UC respectively. Eleven studies, representing 6164 patients (CD = 4858; UC = 1306), were included in the meta‐analysis that examined the impact of diagnostic delay on clinical outcomes. In CD, delayed diagnosis was associated with higher odds of stricturing (OR = 1.88; CI: 1.35–2.62), penetrating disease (OR = 1.64; CI: 1.21–2.20) and intestinal surgery (OR = 2.24; CI: 1.57–3.19). In UC, delayed diagnosis was associated with higher odds of colectomy (OR = 4.13; CI: 1.04–16.40).

Conclusion

Delayed diagnosis is associated with disease progression in CD, and intestinal surgery in both CD and UC. Strategies are needed to achieve earlier diagnosis of IBD.

Subjects

MeSH terms (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansColectomyDelayed Diagnosis

Author keywords

Crohn’s diseaseclinical outcomesdelayed diagnosisinflammatory bowel diseasephenotypesurgerytime to diagnosisulcerative colitis

Authors and institutions

  • Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.
  • Institute of Infection and Immunity, St George's University, London, UK.
  • School of Public Health, Imperial College London, London, UK.
  • Department of Primary Care and Population Health, University College London, London, UK.
  • Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.

ORCID profiles: Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C Pollok

Funding

  • School for Public Health Research

Cite

APA

Jayasooriya, N., Baillie, S., Blackwell, J., Bottle, A., Petersen, I., Creese, H., Saxena, S., Pollok, R. C., & POP-IBD study group (2023). Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 57(6), 635-652. https://doi.org/10.1111/apt.17370

Vancouver

Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, et al. Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2023;57(6):635-652. doi:10.1111/apt.17370

BibTeX
@article{Jayasooriya2023,
  author = {Jayasooriya, Nishani and Baillie, Samantha and Blackwell, Jonathan and Bottle, Alex and Petersen, Irene and Creese, Hanna and Saxena, Sonia and Pollok, Richard C and POP-IBD study group, POP-IBD study group},
  title = {Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {57},
  number = {6},
  pages = {635--652},
  doi = {10.1111/apt.17370}
}
Start for free →